Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Bangladesh

New Pharmaceutical Regulatory Body Established

January 2010 | Industry Trend Analysis

BMI is poised to upgrade Bangladesh's scores for 'policy/reimbursement' and 'approvals process' in our Pharmaceutical Business Environment Ratings, following the creation of the Directorate General of Drug Administration (DGDA). The new medicine regulator is seeking to employ 1,000 staff in addition to the staff it will retain from the former regulator and is set to be fully operational within a year.

To read the full article, please choose one of the following options:

Subcribers please log in